In a recent bid Novavax Inc. [NVAX] faced a contemporary bid of $89.91 yielding a 5.76% incline where 2.53 million shares have exchanged hands over the last week. NVAX amount got a fall by -3.21% or -$2.98 versus $92.89 at the end of the prior session. This change led market cap to move at 5.38B, putting the price 2439.83% below the 52-week high and -52.53% above the 52-week low. The company’s stock has a normal trading capacity of 2.53 million shares while the relative volume is 0.56.
On 10, November 2020, Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020. According to news published on Yahoo Finance, Novavax to host live Q&A due to technical difficulties during quarterly call.
Analyst Birdseye View:
The most recent analyst activity for Novavax Inc. [NASDAQ:NVAX] stock was on August 05, 2020, when it was Upgrade with an Overweight rating from JP Morgan, which also raised its 12-month price target on the stock to $275. Before that, on August 06, 2020, H.C. Wainwright Recapitulated a Buy rating and elevated its amount target to $290. On August 05, 2020, Ladenburg Thalmann Downgrade a Sell rating and boosted its price target on this stock to $105. On July 16, 2020, H.C. Wainwright Reiterated a Buy rating and increased its price target from $101 to $132. On July 08, 2020, Ladenburg Thalmann Downgrade a Neutral rating and increased its price target to $105. On June 29, 2020, H.C. Wainwright Reiterated a Buy rating and boosted its amount target on this stock to $101. On June 29, 2020, B. Riley FBR Reiterated a Buy rating and boosted its target amount on this stock from $74 to $106. On June 05, 2020 JP Morgan Upgrade a Neutral rating and elevated its amount target to $46.
In the past 52 weeks of trading, this stock has oscillated between a low of $3.54 and a peak of $189.40. Right now, the middling Wall Street analyst 12-month amount mark is $211.00. At the most recent market close, shares of Novavax Inc. [NASDAQ:NVAX] were valued at $89.91.
Novavax Inc. [NASDAQ:NVAX] most recently reported quarterly sales of 157.02 billion, which represented growth of 6163.40%.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 86.95 points at 1st support level, the second support level is making up to 84.00. But as of 1st resistance point, this stock is sitting at 93.17 and at 96.43 for 2nd resistance point.
Novavax Inc. [NVAX] reported its earnings at -$3.21 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at $1.73/share signifying the difference of -4.94 and -285.50% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.3 calling estimates for -$0.42/share with the difference of 0.12 depicting the surprise of 28.60%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Novavax Inc. [NASDAQ:NVAX] is 2.80.
The most recent insider trade was by Erck Stanley C, President and CEO, and it was the sale of 52316.0 shares on Nov 16. Erck Stanley C, the President and CEO, completed a sale of 2.0 shares on Oct 01. On Sep 30, Trizzino John, EVP, CBO and CFO, completed a sale of 2250.0 shares.